Biodesix announces second quarter 2023 results and highlights

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the second quarter ended june 30, 2023 and provided a corporate update “i am very pleased to announce another record-setting quarter from our core lung diagnostics,” said scott hutton, president and chief executive officer. “in addition to continued sales growth, we had a number of important publi.
BDSX Ratings Summary
BDSX Quant Ranking